Avacopan

Therapeutic indications

Avacopan is indicated for:

Granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA)

Irrespective of gender only Adults (18 years old or older)

Avacopan, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA).

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 60 mg in 2 divided doses daily

Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner

Related medicines